ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOptions ChainSEC FilingsTrends VRAYQ vs. GMVDF, AHPI, NMRD, MOTS, BRSH, DRTSW, ANZUW, BBLGW, BRSHW, and GMVDWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and G Medical Innovations (GMVDW). These companies are all part of the "medical equipment" industry. ViewRay vs. G Medical Innovations Allied Healthcare Products Nemaura Medical Motus GI Bruush Oral Care Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, community ranking, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Does the MarketBeat Community prefer VRAYQ or GMVDF? ViewRay and G Medical Innovations both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/AG Medical InnovationsN/AN/A Is VRAYQ or GMVDF more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A G Medical Innovations N/A N/A N/A Does the media prefer VRAYQ or GMVDF? In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score. Company Overall Sentiment ViewRay Neutral G Medical Innovations Neutral Which has more volatility and risk, VRAYQ or GMVDF? ViewRay has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 2.69, meaning that its stock price is 169% more volatile than the S&P 500. Do institutionals and insiders have more ownership in VRAYQ or GMVDF? 15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better valuation & earnings, VRAYQ or GMVDF? G Medical Innovations has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AG Medical Innovations$4.42M0.00-$24.63MN/AN/A SummaryG Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$20,000.00$3.55B$5.10B$8.84BDividend YieldN/A1.69%5.04%4.07%P/E RatioN/A12.1695.1214.22Price / SalesN/A90.511,217.3088.42Price / CashN/A47.0339.4936.27Price / BookN/A3.986.976.37Net Income-$107.33M$92.21M$118.73M$225.56M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$20,000.00$102.21M0.00300GMVDFG Medical InnovationsN/AN/AN/AN/A$30,000.00$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150NMRDNemaura MedicalN/AN/AN/AN/A$10,000.00$80,000.000.0040MOTSMotus GIN/A$0.00flatN/A-100.0%$5,000.00$320,000.000.0030BRSHBruush Oral CareN/A$0.00flatN/A-99.7%$1,000.00$2.92M0.0011DRTSWAlpha Tau MedicalN/A$0.22+29.8%N/A-15.4%$0.00N/A0.0080News CoverageGap UpANZUWAnzu Special Acquisition Corp IN/A$0.06flatN/AN/A$0.00N/A0.002BBLGWBone BiologicsN/A$28.49flatN/AN/A$0.00N/A0.002BRSHWBruush Oral CareN/A$0.01flatN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/A$0.02flatN/AN/A$0.00$4.42M0.0072 Related Companies and Tools Related Companies G Medical Innovations Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Bruush Oral Care Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VRAYQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
